Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Common Stock | Options Exercise | $0 | +1.53K | +4.46% | $0.00 | 35.8K | Feb 28, 2022 | Direct | F1 |
transaction | BSX | Common Stock | Tax liability | -$28.3K | -640 | -1.79% | $44.17 | 35.1K | Feb 28, 2022 | Direct | |
holding | BSX | Common Stock | 2.55K | Feb 28, 2022 | By 401(k) | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | BSX | Deferred Stock Units | Options Exercise | $0 | -1.53K | -100% | $0.00* | 0 | Feb 28, 2022 | Common Stock | 1.53K | Direct | F1, F3 |
Id | Content |
---|---|
F1 | Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. |
F2 | Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. |
F3 | Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |